Skip to main
ADUS
ADUS logo

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 60%
Hold 0%
Sell 7%
Strong Sell 0%

Bulls say

Addus HomeCare Corp. is poised for robust growth, particularly within its Hospice segment, which is expected to achieve revenue growth at the high end of 5-7%, supported by stronger admissions and improved leadership strategies. The company's Home Health segment is also showing positive performance with a 1.6% year-over-year revenue increase, driven by optimized case loads and solid operational efficiencies. Additionally, the upward revisions in consensus estimates for 2025, including an 11% increase in revenue projections, indicate a strong market response to Addus's strategic initiatives and potential for further acquisitions to bolster revenue growth targets.

Bears say

Addus HomeCare Corp's stock outlook is negatively influenced by a persistent decline in its Home Health segment, where same-store volumes recorded a year-over-year decrease of -3.2% and new admissions fell by -6.2%. Revenue from Home Health was also disappointing, coming in -2.7% below projections, primarily due to lower volumes despite a partial offset from higher rates. Furthermore, the company's expectation of sequential gross margin compression and lowered adjusted EBITDA estimates for 2025-2027 further underscores concerns regarding its financial stability and growth prospects.

Addus HomeCare (ADUS) has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 15 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Jul 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $118.13, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $118.13, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.